Sana Biotechnology (SANA) Cash from Operations (2020 - 2026)
Sana Biotechnology recorded quarterly Cash from Operations of 37379000.0 in Q1 2026, down 14.52% quarter-over-quarter from 32641000.0 in Q4 2025, and up 23.18% year-over-year from 30345374.21 in Q1 2025.
Sana Biotechnology's Cash from Operations history runs 7 years deep, the most recent figure standing at 37379000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 23.18% year-over-year to 37379000.0; the TTM figure through Mar 2026 stood at 132550000.0 (up 35.71% YoY), while the FY2025 annual figure was 143828000.0, up 35.55% from the prior year.
- Cash from Operations came in at 37379000.0 for Q1 2026 at Sana Biotechnology, down from 32641000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 29429000.0 in Q3 2025 to a low of 79272000.0 in Q1 2023.
- A 5-year average of 55764235.29 and a median of 58541000.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 76.25% in 2022 and jumped 43.46% in 2025, its largest moves.
- Sana Biotechnology's Cash from Operations stood at 76067000.0 in 2022, then surged by 31.69% to 51959000.0 in 2023, then rose by 9.23% to 47161000.0 in 2024, then soared by 30.79% to 32641000.0 in 2025, then slipped by 14.52% to 37379000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 37379000.0, 32641000.0, and 29429000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | -37.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.38 Mn |
| Mar 31, 2026 | -37.38 Mn |
| Dec 31, 2025 | -32.64 Mn |
| Dec 31, 2025 | -32.64 Mn |
| Sep 30, 2025 | -29.43 Mn |
| Sep 30, 2025 | -29.43 Mn |
| Jun 30, 2025 | -33.10 Mn |
| Jun 30, 2025 | -33.10 Mn |
| Mar 31, 2025 | -48.66 Mn |
| Mar 31, 2025 | -48.66 Mn |
| Dec 31, 2024 | -47.16 Mn |
| Dec 31, 2024 | -47.16 Mn |
| Sep 30, 2024 | -51.82 Mn |
| Sep 30, 2024 | -51.82 Mn |
| Jun 30, 2024 | -58.54 Mn |
| Jun 30, 2024 | -58.54 Mn |
| Mar 31, 2024 | -65.63 Mn |
| Mar 31, 2024 | -65.63 Mn |
| Dec 31, 2023 | -51.96 Mn |
| Dec 31, 2023 | -51.96 Mn |
| Sep 30, 2023 | -63.55 Mn |
| Sep 30, 2023 | -63.55 Mn |
| Jun 30, 2023 | -58.80 Mn |
| Jun 30, 2023 | -58.80 Mn |
| Mar 31, 2023 | -79.27 Mn |
| Mar 31, 2023 | -79.27 Mn |
| Dec 31, 2022 | -76.07 Mn |
| Dec 31, 2022 | -76.07 Mn |
| Sep 30, 2022 | -64.80 Mn |
| Sep 30, 2022 | -64.80 Mn |
| Jun 30, 2022 | -71.48 Mn |
| Jun 30, 2022 | -71.48 Mn |
| Mar 31, 2022 | -77.71 Mn |
| Mar 31, 2022 | -77.71 Mn |
| Dec 31, 2021 | -110.10 Mn |
| Dec 31, 2021 | -110.10 Mn |
| Sep 30, 2021 | -50.49 Mn |
| Sep 30, 2021 | -50.49 Mn |
| Jun 30, 2021 | -40.56 Mn |
| Jun 30, 2021 | -40.56 Mn |
| Mar 31, 2021 | -49.91 Mn |
| Mar 31, 2021 | -49.91 Mn |
| Dec 31, 2020 | -37.56 Mn |
| Dec 31, 2020 | -37.56 Mn |
| Sep 30, 2020 | -37.51 Mn |
| Sep 30, 2020 | -37.51 Mn |
| Jun 30, 2020 | -33.37 Mn |
| Jun 30, 2020 | -33.37 Mn |
| Mar 31, 2020 | -29.55 Mn |
| Mar 31, 2020 | -29.55 Mn |